Scientists herald 150 new jabs and pills to tackle obesity going through the research pipeline - but issue urgent warning to ...

A new study suggests that semaglutide, the active ingredient in Ozempic, may help decrease liver fat, inflammation, and ...

First-generation GLP-1 weight-loss drugs can help reduce the risk of obesity-related cancers, new research shows. Liraglutide ...

A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a ...

The findings come after reports of nasty side effects - including eye problems, infections and gastrointestinal disorders - ...

The findings come after reports of nasty side effects - including eye problems, infections and gastrointestinal disorders - ...

New research has found that GLP-1 drugs can substantially reduce the risk of obesity-related cancers — and they’re more ...

Bad reactions to popular weight-loss drugs, including Ozempic and Wegovy, are on track to soar by more than 350 per cent ...